Companies: 48,874 Total Market Cap: 132460447025120.92

Svas Biosana S.p.A.

BIT-SVS
Healthcare Medical Devices
Rank #29624
Market Cap 45.98 M
Volume 3,060
Price 8.65
Change (%) 1.03%
Country or region Italy Italy

Svas Biosana S.p.A.'s latest marketcap:

45.98 M

As of 05/19/2025, Svas Biosana S.p.A.'s market capitalization has reached $45.98 M. According to our data, Svas Biosana S.p.A. is the 29624th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 45.98 M
Revenue (ttm) 137.42 M
Net Income (ttm) 6.60 M
Shares Out 5.31 M
EPS (ttm) 1.24
Forward PE 5.92
Ex-Dividend Date 06/09/2025
Earnings Date 05/15/2025
Market Cap Chart
Data Updated: 05/19/2025

Svas Biosana S.p.A.'s yearly market capitalization.

Svas Biosana S.p.A. has seen its market value drop from €86.80 M to €40.91 M since 2021, representing a total decrease of 52.86% and an annual compound decline rate (CAGR) of 19.92%.
Date Market Cap Change (%)
05/19/2025 €40.91 M 7.32%
12/30/2024 €38.33 M -11.25%
12/29/2023 €43.19 M -20.87%
12/30/2022 €54.58 M -37.13%
12/30/2021 €86.80 M

Company Profile

About SVAS Biosana S.p.A.

SVAS Biosana S.p.A. is a global leader in the production and marketing of high-quality medical devices. Founded in 1972 and headquartered in Somma Vesuviana, Italy, the company specializes in a diverse range of healthcare solutions.

Product Offerings

SVAS Biosana provides innovative medical products across multiple applications, including:

  • Incontinence & Personal Care: Aids and products designed for incontinence management and personal hygiene.
  • Wound Care: Traditional and advanced dressings for effective wound treatment.
  • Surgical & Critical Care: Operating packs, infusion/aspiration devices, and lubricating gels for haemodynamic, heart surgery, anaesthesia, and intensive care.
  • Specialist Medical Devices: Solutions for oncology, chronic illnesses, radiology, orthopaedics, cardiology, and diagnostic imaging.

With decades of expertise, SVAS Biosana S.p.A. remains committed to delivering reliable and advanced medical technologies to improve patient care worldwide.

Frequently Asked Questions

As of 05/19/2025, Svas Biosana S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $45.98 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Svas Biosana S.p.A. global market capitalization ranking is approximately 29624 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Italy
Founded 1972
IPO Date n/a
Employees 323
CEO Umberto Perillo
Sector Healthcare
Industry Medical Devices
Address Via Trentola, 7
Somma Vesuviana
Italy
Website https://svas.it
People Also Watch
ABT
135.55 1.03%
BSX
106.66 1.03%
Stryker
394.69 1.03%
Medtronic plc
86.97 1.03%